Activated Protein C Concentrate: A New Tool for the Treatment of Acute Thromboembolism in Patients with Congenital Protein C Deficiency

• References

• 1 Esmon CT. The regulation of natural anticoagulant pathways. Science 1987; 235: 1348-1351
• 2 Bertina RM, Broekmans AW. Protein C concentrate for therapeutic use. Lancet 1982; 02: 1348
• 3 Nakahira S, Miyata K, Sugawara K, Kamai S, Nakahara Y, Ogata Y, Imamura M, Tanigawa H, Nakagaki T, Miyamoto S, Funatsu A. Characterization of purified protein C derived from human plasma. Iyakuhin Kenkyu (in Japanese) 1994; 25: 1087-1097
• 4 Miyata T, Sakata T, Zheng Y-Z, Tsukamoto H, Umeyama H, Uchiyama S, Ikusawa M, Yoshioka A, Imanaka Y, Fujimura H, Kambayashi J, Kato H. Genetic characterization of protein C deficiency in Japanese subjects using a rapid and nonradioactive method for single-strand conformational polymorphism analysis and a model building. Thromb Haemost 1996; 76: 302-311
• 5 Sakata Y, Curriden S, Lawrence D, Griffin JH, Loskutoff DJ. Activated protein C stimulates the fibrinolytic activity of cultured endothelial cells and decreases antiactivator activity. Proc Natl Acad Sci USA 1985; 82: 1121-1125